By means of the protein immunoblot technique, the Epstein-Barr virus (EBV) nuclear antigen (EBNA) could be identified in a variety of EBV-transformed cell lines with anti-EBNA-positive sera from normal donors. The molecular weight of EBNA expressed in each of the cell lines varied between 70,000 and 75,000 and was dependent upon the strain of infecting virus. In contrast, 15 of 21 sera from patients with rheumatoid arthritis identified antigens in addition to EBNA. The most prominent of these antigens had molecular weights of 110,000 to 115,000 and 92,000. All of the EBV genome-positive cell lines except for QIMR-GOR and cell lines containing the P3HR-1 virus expressed these antigens. The antigens were not present in the EBV genomenegative Ramos and BJAB cell lines, nor were they identified with EBV seronegative sera, indicating that they were EBV related. There was no direct correlation between the presence of antibodies in sera to EBNA, viral capsid antigen or early antigen, and reaction with the 92,000-molecular-weight antigen in immunoblots, indicating that this antigen was distinct from previously described EBV-related antigens. 25% (vol/vol), and stored at -80°C.
Nonpermissive infection of human lymphocytes by Epstein-Barr virus (EBV) results in the expression of the Epstein-Barr virus nuclear antigen (EBNA) (21) . EBNA is the only antigen that can be directly observed in EBVtransformed lymphocytes, and as such, it has been suggested to be involved in the transformation process. Recent reports, however, have indicated that additional EBV-induced antigens may also be expressed in EBV-transformed lymphocytes. Strnad et al. (24) , using fluoroimmunoelectrophoresis to detect EBNA, noted the presence of an additional 81,000-molecular-weight (81K) antigen in B95-8 and Raji cells. Spelsberg et al. (23) presented evidence for the existence of two distinct components of the EBV-induced nuclear antigen in NC37 cells. Hennessy and Kieff (7), employing protein immunoblots, observed that some EBV-immune human antisera recognized a second intracellular antigen that was specific for latently infected cells. They found that the molecular weight of EBNA varied from 68K to 85K among cells transformed by different EBV isolates, but that the second antigen had a consistent molecular weight of 82K in each of the cell lines. By means of cotransformation of LTK-cells, Grogan et al. (5) identified the BamHI K fragment of the EBV genome as encoding or inducing EBNA. They also found that a second EBV DNA fragment, BamHI-M, was able to give rise to cotransformed LTKcells with stable expression of a second distinct nuclear antigen.
The possible existence of multiple EBV-induced antigens in EBV-transformed cells is consistent with the data of Powell et al. (20) , which showed that Raji and Namalwa cells contain sufficient EBV-specific RNA to code for up to four proteins. Some of the "additional" nuclear antigens report 25% (vol/vol) , and stored at -80°C.
Sera. The EBV titers of the sera collected from clinically normal individuals and patients diagnosed as having rheumatoid arthritis are shown in Table 2 . The criteria used for diagnosing patients with rheumatoid arthritis are presented in a previous study (16) . Anti-EBNA titers were measured according to the method of Reedman and Klein (21) . Anti-VCA (viral capsid antigen) and anti-EA (early antigen) titers were measured as described by Henle and Henle (6) and Klein and Dombos (10) , respectively.
Preparation of cell fractions. Frozen cells were allowed to thaw and were collected by centrifugation at 2,000 x g for 5 min. The cells were suspended in nuclei isolation buffer containing 0.5% (vol/vol) Triton X-100, left on ice for 5 min, and collected by centrifugation at 2,000 x g for 5 min. This process was repeated twice more, and the final pellet represented purified nuclei. The pooled supernatants from each of these centrifugations represented the cytosol fraction.
A nuclear extract was prepared by suspending purified nuclei in 0.4 M NaCI-20 mM Tris-hydrochloride [pH 7.4]-0.1 mM PMSF and incubating them at 4°C for 5 min. The nuclei were collected by centrifugation. This extraction of nuclei was repeated once. The two extracts were pooled, and the combined preparation was clarified by centrifugation (10, Polyacrylamide gel electrophoresis. Composition and electrophoresis of SDS-10% (wt/vol) polyacrylamide slab gels were essentially as reported by Laemmli (14) . Electrophoresis was performed at 100 V for 16 h at 0 to 4°C.
Protein immunoblot. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose paper (Bio-Rad Laboratories, Richmond, Calif.) and detection of antigens with antibody and radioiodinated protein A (70 to 100 ,uCi/,ug) (New England Nuclear Corp., Boston, Mass.) were performed essentially as described by Burnette (2) , except that the transfer buffer contained 0.05% SDS. Samples of protein standards (Pharmacia, Uppsala, Sweden) were iodinated by using 1251 and lodo-Beads (Pierce Chemical Co., Rockford, Ill.). These were subjected to electrophoresis alongside cell extracts and were similarly transferred to nitrocellulose paper.
RESULTS
Detection of EBV-induced antigens by the use of sera from normal donors. SDS extracts were prepared from 12 EBV genome-positive and 2 genome-negative cell lines, and these extracts were electrophoresed in SDS-10% polyacrylamide gels. The proteins were then electrophoretically transferred to nitrocellulose paper, and EBV-induced antigens were detected with anti-EBNA-positive serum from clinically normal individuals. EBNAs, and CRUK and QIMR-GOR viruses caused expression of 71K EBNAs. The Raji cell line was found to express a 70K EBNA. Many of the anti-EBNA-positive sera reacted with a 25K antigen present in the P3HR-1, QIMR-WIL, and QIMR-GOR cell lines. This antigen was probably a VCA component since it was present only in cell lines that produced virus and was detected with anti-VCA-positive, anti-EAnegative sera. Also, stimulation of P3HR-1 with sodium butyrate resulted in an increase in the 25K antigen, whereas the amount of EBNA remained relatively constant (unpublished data). Two other antigens with molecular weights of 40K and 43K were also noted in EHRB-Ramos and P3HR-1 cells, respectively, though the significance of these antigens is unknown.
Detection of EBV-induced antigens with arthritis sera. JA cells were used to prepare SDS extracts, and these extracts were electrophoresed on SDS-10% polyacrylamide gels and transferred onto nitrocellulose papers. The papers were incubated with sera obtained from patients diagnosed as having rheumatoid arthritis ( Table 2 ). All anti-EB3NA-positive rheumatoid sera reacted with EBNA, but a large proportion of these sera also detected additional antigens (Fig. 2) . These antigens had molecular weights of 115K, 110K, 92K, 55K, and 45K. The most prominent of these additional antigens had a molecular weight of 92K, and the proportion of sera that reacted with this antigen is shown in other than EBNA or the 92K protein could not be accurately determined since many of the rheumatoid sera gave high backgrounds which effectively masked the other minor antigens.
It has been reported that a large proportion of arthritis sera, particularly rheumatoid sera (1), contain antinuclear antibodies, and it was possible that the additional antigens detected in JA cells were simply components that react with antinuclear antibodies. If these antigens were EBV specific, the sera should show a similar reaction with other EBV genome-positive cell lines but no reaction with EBV genome-negative cell lines. SDS extracts from 12 EBV genome-positive cell lines as well as the EBV genomenegative cell lines Ramos and BJAB were subjected to electrophoresis and were then transferred onto nitrocellulose paper. The papers were incubated with five of the rheumatoid sera, each of which had previously reacted with the 92K antigen in JA cells; the results from two of these sera are shown in Fig. 3 . All of the sera tested gave the same results; none of the antigens detected in JA cells were identified in either Ramos or BJAB cells, indicating that they were EBV induced. Unlike EBNA, the 92K antigen exhibited a consistent molecular weight in each of the lines in which it was present. Likewise, the 110 to 115K antigens also appeared to display the same molecular weights in each of the EBV genome-positive cell lines, except for the lines that lacked the 92K antigen. In these cases, either the 110 to 115K antigens were undetectable or the molecular weights were altered. The Anti-EBNA-positive sera from rheumatoid arthritis pa-FIG. 3 . Detection of antigens in different cell lines by using sera from patients with rheumatoid arthritis. SDS extracts were prepared from different cell lines and electrophoresed on SDS-10% polyacrylamide gels. Proteins were then transferred to nitrocellulose and incubated with sera from rheumatoid arthritis patients (A, serum 2; B, serum 9). Lanes: 1, B95-8; 2, JT; 3, Raji; 4, JA; 5, BJAB; 6, BK B95-8; 7, BK CRUK; 8, BJAB B95-8; 9, QIMR-GOR; 10, QIMR-WIL; 11, P3HR-1; 12, AW-Ramos; 13, EHRB-Ramos; 14, Ramos. The position of EBNA is indicated. The positions to which protein standards migrated are also indicated. cells. As these lines produce virus, and as the rheumatoid sera used in these tests contain anti-VCA and anti-EA antibodies, these antigens may be involved in virus replication. Additional antigens were also noted in each of the lines transformed by the QIMR-WIL virus, though the number and molecular weights of these antigens were different in each of the lines. These results indicate that, although a particular strain of virus may be able to induce antigens in cells, the cell line apparently has some control over the type or molecular weight of these antigens.
Cellular localization of antigens. The intracellular distribution of each of the EBV-related antigens was investigated by preparing cytoplasmic and nuclear extracts of JA cells and subjecting samples of these extracts to electrophoresis and transfer onto nitrocellulose paper. Antigens were then detected with an anti-EBNA-positive, anti-92K-positive rheumatoid serum. EBNA was present in all of the extracts, as tients also identified variations in the molecular weight of EBNA in different cell lines, but many of these sera reacted with a number of additional antigens in EBV genomepositive cells. The most prominent of these additional antigens had a molecular weight of 92K, and, unlike EBNA, it maintained the same molecular weight in each of the cell lines in which it was present. Had this antigen varied in molecular weight according to the strain of infecting virus, it would have supported the concept that it was a viral product. Although the reverse may not be true, it leaves open the possibility that the antigen is a cellular protein induced by EBV. In either case, the inability of P3HR-1 to induce the 92K antigen suggests that the product of the 3.7-kilobase mRNA transcribed from the IR1-U2 region of the EBV genome (a section of which is deleted in P3HR-1) may be required for expression of the antigen (20) .
Although only EBV-seropositive rheumatoid sera detected the 92K antigen, there was no obvious correlation between anti-EBNA, anti-VCA, and anti-EA titers of the sera and reaction with the 92K antigen. Further evidence that the 92K antigen was not related to either EA or VCA components stems from the fact that it was absent from QIMR-GOR and P3HR-1 cells, both of which express EA and VCA components. The absence of the antigen from four of the cell lines expressing EBNA, and the absence of antibodies to the 92K antigen in many anti-EBNA-positive sera, suggest that the 92K antigen and EBNA are also unrelated.
The absence of the 92K antigen in the cell lines harboring the nontransforming P3HR-1 strain of EBV suggests that the antigen may be directly involved in the transformation process. The QIMR-GOR cell line also failed to express the 92K antigen. This cell line produced transforming virus at one stage (19) , and though it is still an active VCA producer, recent attempts to obtain transforming virus have failed (unpublished data).
Each of the cell lines not expressing the 92K antigen also either lacked or had altered 110 to 115K antigens, indicating a possible relationship among all of these antigens. Because of the apparently small amounts of the 110 to 115K antigens present in EBV-transformed cells and the high backgrounds obtained with many of the rheumatoid sera in the immunoblots, it was not possible to determine whether a correlation existed between the presence of anti-92K antibodies and anti-110 to 115K antibodies. A number of additional smallmolecular-weight antigens were also detected in cells transformed by either the QIMR-WIL or CRUK viruses. Since these antigens were not present in all of the lines which expressed EBNA or the 92K antigen, it is unlikely that they are related. It is possible that the QIMR-WIL and CRUK viruses could contain additional genetic information coding for these small-molecular-weight antigens.
Cell fractionation studies suggested that both the 92K antigen an1 EBNA were present within the nucleus, and that at least a portion of each of these antigens was tightly associated with the chromatin, requiring 2 M NaCl for complete removal. EBNA has previously been shown to bind DNA (9) , and the present results indicate that the 92K antigen may serve a similar function.
Antigens with characteristics somewhat similar to those of the 92K antigen have previously been reported. Strnad et al. (24) described an 81K antigen present in Raji and B95-8 cells. Hennessy and Kieff (7) identified an EBV-induced 82K antigen in five EBV genome-positive cell lines and termed this antigen EBNA 2. Like the 92K antigen, the 81K antigen and EBNA 2 maintained the same molecular weight in each of the cell lines in which they were present. Also, both antigens were found to be associated with the nucleus. Although similarities exist between the 81K antigen, EBNA 2, and the 92K antigen, there is a considerable difference in their estimated molecular weights, indicating that they may in fact be distinct antigens. Variation in the polyacrylamide concentration or buffer composition of gels, or temperature and time of electrophoresis, had no significant effect upon the estimated molecular weight of the 92K antigen. Only a direct comparison employing sera used to identify each of the antigens could resolve the question.
The 92K antigen was not detected with most of the sera from normal individuals used in this study, or by normal sera used in other studies (22; Sculley et al., in press). Many normal sera, however, may contain very low-titered antibody to the 92K antigen, since if they are used at less than a 1:10 dilution, a faint reaction with the 92K antigen can be detected. The antigen could be a cellular protein induced by EBV, such as a differentiation antigen or a cellular oncogene product, though it may still be related to viral function in some way. It is possible that antibodies to the 92K antigen are not restricted to rheumatoid arthritis but are present in other diseases that elicit an autoantibody-type response, and studies along these lines are currently in progress.
Although the results presented in this paper suggest a high incidence of anti-92K antibodies in rheumatoid sera compared with the general population, the normal sera were from individuals who were neither age nor sex matched to the rheumatoid patients. The purpose of this paper was not to compare rheumatoid and normal sera, but to demonstrate the presence of apparently new EBV-related antigens in EBV-transformed cells by using rheumatoid sera. The study of these antigens may shed some light on both the mechanism by which EBV transforms lymphocytes and the pathogenesis of rheumatoid arthritis.
